188 related articles for article (PubMed ID: 8580226)
1. Cerebrospinal fluid gamma-aminobutyric acid in patients with panic disorder.
Rimón R; Lepola U; Jolkkonen J; Halonen T; Riekkinen P
Biol Psychiatry; 1995 Dec; 38(11):737-41. PubMed ID: 8580226
[TBL] [Abstract][Full Text] [Related]
2. Growing placebo response rate: the problem in recent therapeutic trials?
Uhlenhuth EH; Matuzas W; Warner TD; Thompson PM
Psychopharmacol Bull; 1997; 33(1):31-9. PubMed ID: 9133749
[TBL] [Abstract][Full Text] [Related]
3. [Comparison of the effect of alprazolam, imipramine and placebo in the treatment of panic disorders in Cali, Colombia].
León CA; De Arango MV; Arevalo W; Calvo A; Montoya A; León A
Acta Psiquiatr Psicol Am Lat; 1990; 36(1-2):59-72. PubMed ID: 2073024
[TBL] [Abstract][Full Text] [Related]
4. Cognitive behavior therapy for treatment-refractory panic disorder.
Pollack MH; Otto MW; Kaspi SP; Hammerness PG; Rosenbaum JF
J Clin Psychiatry; 1994 May; 55(5):200-5. PubMed ID: 8071270
[TBL] [Abstract][Full Text] [Related]
5. Pretreatment anxiety level as differential predictor in outpatients with panic disorder.
Scheibe G; Nutzinger D; Buller R; Walther AU
Arzneimittelforschung; 1992 Sep; 42(9):1090-4. PubMed ID: 1445474
[TBL] [Abstract][Full Text] [Related]
6. Drug treatment of panic disorder: the comparative efficacy of imipramine, alprazolam, and trazodone.
Charney DS; Woods SW; Goodman WK; Rifkin B; Kinch M; Aiken B; Quadrino LM; Heninger GR
J Clin Psychiatry; 1986 Dec; 47(12):580-6. PubMed ID: 3536889
[TBL] [Abstract][Full Text] [Related]
7. [Patients with panic disorder: a 5-year follow-up study].
León CA; Arévalo W; Gaviria LF; Leon A
Acta Psiquiatr Psicol Am Lat; 1992 Dec; 38(4):279-88. PubMed ID: 1341123
[TBL] [Abstract][Full Text] [Related]
8. Treatment of panic disorder in older adults: a pilot study comparison of alprazolam, imipramine, and placebo.
Sheikh JI; Swales PJ
Int J Psychiatry Med; 1999; 29(1):107-17. PubMed ID: 10376237
[TBL] [Abstract][Full Text] [Related]
9. Cerebrospinal fluid GABA levels in chronic migraine with and without depression.
Vieira DS; Naffah-Mazacoratti MG; Zukerman E; Senne Soares CA; Alonso EO; Faulhaber MH; Cavalheiro EA; Peres MF
Brain Res; 2006 May; 1090(1):197-201. PubMed ID: 16638608
[TBL] [Abstract][Full Text] [Related]
10. Treatment of panic disorder.
Cassano GB; Toni C; Musetti L
Adv Biochem Psychopharmacol; 1992; 47():449-60. PubMed ID: 1509926
[No Abstract] [Full Text] [Related]
11. Psychopathology of panic attacks in panic disorder.
Uhlenhuth EH; Leon AC; Matuzas W
J Affect Disord; 2006 May; 92(1):55-62. PubMed ID: 16448702
[TBL] [Abstract][Full Text] [Related]
12. Augmentation strategies with tricyclic or fluoxetine treatment in seven partially responsive panic disorder patients.
Tiffon L; Coplan JD; Papp LA; Gorman JM
J Clin Psychiatry; 1994 Feb; 55(2):66-9. PubMed ID: 8077156
[TBL] [Abstract][Full Text] [Related]
13. Cognitive style, alprazolam plasma levels, and treatment response in panic disorder.
Uhlenhuth EH; Starcevic V; Qualls C; Antal EJ; Matuzas W; Javaid JI; Barnhill J
Depress Anxiety; 2008; 25(8):E18-26. PubMed ID: 17960759
[TBL] [Abstract][Full Text] [Related]
14. Panic disorder patients at the time of air strikes.
Starcevic V; Kolar D; Latas M; Bogojevic G; Kelin K
Depress Anxiety; 2002; 16(4):152-6. PubMed ID: 12497646
[TBL] [Abstract][Full Text] [Related]
15. A naturalistic 6-year follow-up study of patients with panic disorder.
Lepola U; Koponen H; Leinonen E
Acta Psychiatr Scand; 1996 Mar; 93(3):181-3. PubMed ID: 8739663
[TBL] [Abstract][Full Text] [Related]
16. Cerebrospinal fluid gamma-aminobutyric acid and homovanillic acid in depressive disorders.
Kasa K; Otsuki S; Yamamoto M; Sato M; Kuroda H; Ogawa N
Biol Psychiatry; 1982 Aug; 17(8):877-83. PubMed ID: 7115838
[TBL] [Abstract][Full Text] [Related]
17. Panic disorder: long-term pharmacotherapy and discontinuation.
Rickels K; Schweizer E
J Clin Psychopharmacol; 1998 Dec; 18(6 Suppl 2):12S-18S. PubMed ID: 9872708
[TBL] [Abstract][Full Text] [Related]
18. A comparison of symptom determinants of patient and clinician global ratings in patients with panic disorder and depression.
Leon AC; Shear MK; Klerman GL; Portera L; Rosenbaum JF; Goldenberg I
J Clin Psychopharmacol; 1993 Oct; 13(5):327-31. PubMed ID: 8227491
[TBL] [Abstract][Full Text] [Related]
19. A three-year follow-up study of patients with the respiratory subtype of panic disorder after treatment with clonazepam.
Nardi AE; Valença AM; Nascimento I; Lopes FL; Mezzasalma MA; Freire RC; Veras AB; Zin WA; Versiani M
Psychiatry Res; 2005 Nov; 137(1-2):61-70. PubMed ID: 16226812
[TBL] [Abstract][Full Text] [Related]
20. Anxiety psychopathology predictive of outcome in patients with panic disorder and depression treated with imipramine, alprazolam and placebo.
Pollack MH; Otto MW; Sachs GS; Leon A; Shear MK; Deltito JA; Keller MB; Rosenbaum JF
J Affect Disord; 1994 Apr; 30(4):273-81. PubMed ID: 8014326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
